15 filings
8-K
ARDS
Aridis Pharmaceuticals, Inc.
30 Dec 19
Regulation FD Disclosure
2:50pm
8-K
ARDS
Aridis Pharmaceuticals, Inc.
13 Nov 19
Aridis Pharmaceuticals Announces Third Quarter 2019 Results
4:25pm
8-K
ARDS
Aridis Pharmaceuticals, Inc.
11 Oct 19
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
4:16pm
8-K
ARDS
Aridis Pharmaceuticals, Inc.
3 Oct 19
Entry into a Material Definitive Agreement
12:00am
8-K
ARDS
Aridis Pharmaceuticals, Inc.
27 Sep 19
Aridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
10:41am
8-K
l0g9 0f79dlu2b1q4ew
9 Sep 19
Other Events
3:42pm
8-K
uljuid9rts6
3 Sep 19
Other Events
9:53am
8-K
edtzeyhoqzq
14 Aug 19
Submission of Matters to a Vote of Security Holders
12:00am
8-K
bl8hclkfg phc1g4p
12 Aug 19
Aridis Pharmaceuticals Announces Second Quarter 2019 Results
4:11pm
8-K
lyfkn1d42d bq6m
30 Jul 19
Entry into a Material Definitive Agreement
4:06pm
8-K
ggt8hbw9urfky
27 Jun 19
Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501
4:00pm
8-K
fku2f
10 Jun 19
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
8:40am
8-K
5c6rin8c7gjx 2vbinv
14 May 19
Aridis Pharmaceuticals Announces First Quarter 2019 Results
4:54pm
8-K
o0tcl6gnnb1s3
28 Mar 19
Aridis Pharmaceuticals Announces 2018 Fourth Quarter and Year-End Financial Results and Business Update
4:17pm
8-K
o79162
27 Feb 19
Termination of a Material Definitive Agreement
4:04pm
- Prev
- 1
- Next